Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by E. Mayen-Herrera
PRS4 Economic Evaluation of the Use of Palivizumab as Prophylactic Treatment for the Reduction of Complications Associated With Respiratory Syncytial Virus in Pre-Term Patients
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Related publications
4cps-069 Evaluation of Palivizumab as Prophylaxis Against Respiratory Syncytial Virus Infection
The Effect of Palivizumab Prophylaxis on Respiratory Syncytial Virus-Associated Hospitalizations in Infants With Congenital Diaphragmatic Hernia
Pediatrics and Neonatology
Child Health
Pediatrics
Perinatology
Comparison of Intravenous Palivizumab and Standard of Care for Treatment of Respiratory Syncytial Virus Infection in Mechanically Ventilated Pediatric Patients
Journal of Pediatric Pharmacology and Therapeutics
Child Health
Pediatrics
Perinatology
Pharmacology
Assessing Variation in the Cost of Palivizumab for Respiratory Syncytial Virus Prevention in Preterm Infants
PharmacoEconomics - Open
Health Policy
Pharmacology
Respiratory Syncytial Virus (RSV) Immune Globulin and Palivizumab for Prevention of RSV Infection
American Journal of Health-System Pharmacy
Medicine
Health Policy
Pharmacology
Pharmacy
Hospital Admission of High Risk Infants for Respiratory Syncytial Virus Infection: Implications for Palivizumab Prophylaxis
Archives of Disease in Childhood: Fetal and Neonatal Edition
Pediatrics
Gynecology
Perinatology
Obstetrics
Medicine
Child Health
Viral Load in Respiratory Syncytial Virus Infected Premature Newborns Under Prophylaxis With Palivizumab
Virology: Research and Reviews
Hyponatremia in Patients With Respiratory Syncytial Virus Bronchiolitis
Pediatric Health, Medicine and Therapeutics
In Vivo Selection of Respiratory Syncytial Viruses Resistant to Palivizumab
Journal of Virology
Insect Science
Immunology
Microbiology
Virology
